Hendrik Liebers
Chairman at Novoplant GmbH
Profile
Presently, Hendrik Liebers is Chairman-Supervisory Board of Novoplant GmbH.
In the past Dr. Liebers occupied the position of Chief Financial Officer for Vivoryon Therapeutics AG, Principal at Connecting for Health, Managing Director & Head-Finance Department at Ingenium Pharmaceuticals GmbH, Investment Director at CFH Management GmbH and Head-Life Science at IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH.
He received a doctorate from Universität Leipzig and an undergraduate degree from Eberhard Karls Universität Tübingen.
Hendrik Liebers active positions
Companies | Position | Start |
---|---|---|
Novoplant GmbH
Novoplant GmbH Agricultural Commodities/MillingProcess Industries Novoplant GmbH develops and provides veterinary medicines. It produces antibodies and antibody fragments in plants for veterinary use to fight intestinal pathogens. It received a license for the development and commercialization of therapeutic antibodies as feed components for use in veterinary medicine. It will use MorphoSys’s HuCAL GOLD technology to generate antibodies against viruses, parasites and pathogenic microorganisms. The addition of such antibodies to animal feed stock may offer protection against infectious diseases in the respective animal’s gastro-intestinal tract. The company was founded in 1998 and is headquartered in Gatersleben, Germany. | Chairman | - |
Former positions of Hendrik Liebers
Companies | Position | End |
---|---|---|
VIVORYON THERAPEUTICS N.V. | Director of Finance/CFO | 2018-04-29 |
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg. | Corporate Officer/Principal | 2007-07-31 |
CFH Management GmbH
CFH Management GmbH Investment ManagersFinance CFH Beteiligungsgesellschaft mbH (CFH) is the investment arm and a wholly-owned subsidiary Landesbank Baden-Württemberg. CFH was founded in 1996 and is headquartered in Leipzig on the eastern side of Germany. CFH manages private equity funds including regional funds focused on Saxony and venture capital funds. They also manage a portfolio of direct participations and a private equity fund of fund. In addition to their parent Sachsen Landesbank and the Government of Land Sachsen, their investors include large regional savings banks and European entities. | Chief Investment Officer | - |
Ingenium Pharmaceuticals GmbH
Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany. | Director of Finance/CFO | - |
Connecting for Health
Connecting for Health Internet Software/ServicesTechnology Services Connecting for Health addresses the challenges of protected health information between sub-network organizations on a nationwide health information network. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of Hendrik Liebers
Eberhard Karls Universität Tübingen | Undergraduate Degree |
Universität Leipzig | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VIVORYON THERAPEUTICS N.V. | Health Technology |
Private companies | 6 |
---|---|
Ingenium Pharmaceuticals GmbH
Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany. | Commercial Services |
CFH Management GmbH
CFH Management GmbH Investment ManagersFinance CFH Beteiligungsgesellschaft mbH (CFH) is the investment arm and a wholly-owned subsidiary Landesbank Baden-Württemberg. CFH was founded in 1996 and is headquartered in Leipzig on the eastern side of Germany. CFH manages private equity funds including regional funds focused on Saxony and venture capital funds. They also manage a portfolio of direct participations and a private equity fund of fund. In addition to their parent Sachsen Landesbank and the Government of Land Sachsen, their investors include large regional savings banks and European entities. | Finance |
Novoplant GmbH
Novoplant GmbH Agricultural Commodities/MillingProcess Industries Novoplant GmbH develops and provides veterinary medicines. It produces antibodies and antibody fragments in plants for veterinary use to fight intestinal pathogens. It received a license for the development and commercialization of therapeutic antibodies as feed components for use in veterinary medicine. It will use MorphoSys’s HuCAL GOLD technology to generate antibodies against viruses, parasites and pathogenic microorganisms. The addition of such antibodies to animal feed stock may offer protection against infectious diseases in the respective animal’s gastro-intestinal tract. The company was founded in 1998 and is headquartered in Gatersleben, Germany. | Process Industries |
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg. | Finance |
Connecting for Health
Connecting for Health Internet Software/ServicesTechnology Services Connecting for Health addresses the challenges of protected health information between sub-network organizations on a nationwide health information network. The company is headquartered in New York, NY. | Technology Services |
Novosom Verwaltungs GmbH
Novosom Verwaltungs GmbH BiotechnologyHealth Technology Novosom Verwaltungs GmbH provides clinical development services and hospital equipment. It offers its own euqipment and technology to discover new methods of healing and researching on ribonucleic acid. The company was founded by Steffen Panzner in 1999 and is headquartered in Halle, Germany. | Health Technology |